[1]郑 阳,宿 濛,陈 涛,等.加味小陷胸汤基于核因子-κB信号通路对非小细胞肺癌荷瘤小鼠的影响实验研究[J].陕西中医,2021,(1):23-28.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.005]
　ZHENG Yang,SU Meng,CHEN Tao,et al.Effect of Jiawei Xiaoxianxiong decoction on non-small cell lung cancer mice based on NF-κB signaling pathway[J].,2021,(1):23-28.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.005]
点击复制

加味小陷胸汤基于核因子-κB信号通路对非小细胞肺癌荷瘤小鼠的影响实验研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年1期
页码:
23-28
栏目:
基础研究
出版日期:
2021-01-05

文章信息/Info

Title:
Effect of Jiawei Xiaoxianxiong decoction on non-small cell lung cancer mice based on NF-κB signaling pathway
作者:
郑 阳1; 宿 濛2; 陈 涛1; 王永鹏3
(1.辽宁省肿瘤医院检验科,辽宁 沈阳 110000; 2.辽宁省肿瘤医院消化科,辽宁 沈阳 110000; 3.辽宁省肿瘤医院结直肠外科,辽宁 沈阳 110000)
Author(s):
ZHENG Yang; SU Meng; CHEN Tao; WANG Yongpeng
(Department of Laboratory,Liaoning Cancer Hospital,Shenyang 110000,China)
关键词:
加味小陷胸汤;  非小细胞肺癌;  小鼠;  核因子κB信号通路;  B淋巴细胞瘤-2;  Bcl-2相关X蛋白
Keywords:
Jiawei Xiaoxianxiong decoction;  Non-small cell lung cancer;  Mice;  Nuclear factor κB signaling pathway;  Bcl-2;  Bcl-2 related X protein
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2020.01.005
文献标志码:
A
摘要:
目的:探讨加味小陷胸汤基于核因子κB(NF-κB)信号通路对非小细胞肺癌荷瘤小鼠的影响。方法:选取SPF级健康雄性C57BL/6小鼠75只,分为对照组15只和造模组60只。造模组采用人非小细胞肺癌A549细胞株右腋下接种建立非小细胞肺癌荷瘤模型,对照组给予等量生理盐水右腋下皮下注射。造模成功后,将造模组小鼠随机分为模型组、加味小陷胸汤低、高浓度组及顺铂组,各15只。模型组和对照组分别予以无菌生理盐水5 ml/kg,腹腔注射,1次/d +蒸馏水5 ml/kg,灌胃,1次/d; 加味小陷胸汤低、高浓度组分别予以无菌生理盐水5 ml/kg,腹腔注射,1次/d +8 mg/ml、16 mg/ml加味小陷胸汤药液5 ml/kg,灌胃,1次/d; 顺铂组予以0.4 mg/ml顺铂溶液5 ml/kg,腹腔注射,1次/d +蒸馏水5 ml/kg,灌胃,1次/d。所有小鼠均连续给药14 d。对小鼠肿瘤体积、瘤重和生长抑制率、肿瘤组织细胞凋亡率、肿瘤组织含半胱氨酸的天冬氨酸蛋白水解酶-3(Caspase-3)、NF-κB、B淋巴细胞瘤-2(Bcl-2)、Bcl-2相关X蛋白(Bax)表达水平进行检测。结果:治疗后,与模型组比较,各组小鼠肿瘤体积、瘤重较低,肿瘤组织NF-κB、Bcl-2表达水平较低,且加味小陷胸汤低浓度组>加味小陷胸汤高浓度组和顺铂组,差异有统计学意义(P<0.05)。与模型组比较,各组小鼠肿瘤生长抑制率较高,肿瘤组织细胞凋亡率较高,肿瘤组织Bax、Caspase-3表达水平较高,且加味小陷胸汤低浓度组<加味小陷胸汤高浓度组和顺铂组,差异有统计学意义(P<0.05)。结论:加味小陷胸汤能剂量依赖性抑制非小细胞肺癌荷瘤小鼠肿瘤生长,促进肿瘤细胞凋亡,其作用可能与抑制NF-κB信号通路,调节凋亡相关蛋白Bcl-2、Bax、Caspase-3表达有关。
Abstract:
Objective:To analysis the effect of Jiawei Xiaoxianxiong decoction on non-small cell lung cancer mice based on nuclear factor-κB(NF-κB)signaling pathway.Methods:75 SPF healthy male C57BL/6 mice were selected,which were divided into control group with 15 mice and model building group with 60 mice.Non-small cell lung cancer models were established by right axillary inoculation of human non-small cell lung cancer A549 cell line in model building group,and mice in the control group were given the same amount of saline by subcutaneous injection under right axilla.After the establishment of the model,mice in model building group were randomly divided into model group,Jiawei Xiaoxianxiong decoction low-concentration group,Jiawei Xiaoxianxiong decoction high-concentration group and cisplatin group,each with 15 mice.The model group and control group were given aseptic saline 5 ml/kg,ip,qd+distilled water 5 ml/kg,ig,qd; Jiawei Xiaoxianxiong decoction low-concentration group,Jiawei Xiaoxianxiong decoction high-concentration group were given aseptic saline 5 ml/kg,ip,qd+8 mg/ml,16 mg/ml Xiaoxianxiong decoction suspension 5 ml/kg,ip,qd; cisplatin group was given 0.4 mg/ml cisplatin solution 5 ml/kg,ip,qd + distilled water 5 ml/kg,ig,qd.All mice were given 14 d of continuous administration.The tumor volume,tumor weight and growth inhibition rates,apoptosis rates of tumor tissue,expression levels of cysteine-containing aspartate proteolytic enzyme-3(caspase-3),NF-κB,Bcl-2 and Bcl-2 related X protein(Bax)in tumor tissues were detected.Results:After treatment,compared with model control group,the tumor volume and tumor weight were lower,expression levels of NF-κB,Bcl-2 in tumor tissues were lower in each group,and Jiawei Xiaoxianxiong decoction low-concentration group > Jiawei Xiaoxianxiong decoction high-concentration group and cisplatin group,the difference was statistically significant(P<0.05).Compared with model control group,the inhibition rates of tumor growth were higher,the apoptotic rates of tumor tissue were higher,and the expression levels of Bax and Caspase-3 in tumor tissue were higher in each group,and Jiawei Xiaoxianxiong decoction low-concentration group < Jiawei Xiaoxianxiong decoction high-concentration group and cisplatin group,the difference was statistically significant(P<0.05).Conclusions:Jiawei Xiaoxianxiong decoction can inhibit the growth of non-small cell lung cancer-bearing mice in a dose-dependent manner,promote apoptosis of cancer cells,the effect may be related to inhibiting the signal pathway of NF-κB,and regulating the expressions of apoptosis-related proteins Bcl-2,Bax and Caspase-3.

参考文献/References:

[1] 宋 勇,高健伟.精准医学时代的晚期非小细胞肺癌内科治疗进展[J].医学研究生学报,2017,30(10):1127.
[2] 陈万青,左婷婷,郑荣寿,等.2013年中国肺癌发病与死亡分析[J].中华肿瘤杂志,2017,39(10):795-800.
[3] 王丽萍.肺癌免疫治疗现状及展望[J].中华实用诊断与治疗杂志,2017,31(2):105-110.
[4] Chen WT,Chen YK,Lin SS,et al.Hyperforin suppresses tumor growth and mediated anti-apoptotic and invasive potential of non-small cell lung cancer[J].Anti Cancer Research,2018,38(4):2161-2167.
[5] 程 权,傅华洲.中药复方辅助治疗非小细胞肺癌研究进展[J].辽宁中医药大学学报,2016,18(1):141-144.
[6] 王珊珊,谭光波.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFN-γ、IL-4表达水平影响研究[J].陕西中医,2019,40(11):1491-1494.
[7] 罗满林.实验动物学[M].北京:人民卫生出版社,2017:274-278.
[8] Brandon G,Anita L,Robert J,et al.The function and therapeutic targeting of anaplastic lymphoma kinase(ALK)in non-small cell lung cancer(NSCLC)[J].Molecular Cancer,2018,17(1):52.
[9] 王兰兰,许化溪.临床免疫学检验[M].北京:人民卫生出版社,2012:145-147,212-217.
[10] 中国协和医科大学.医学分子生物学实验教程[M].北京:人民卫生出版社,2018:303-305.
[11] 陈石秀,陈佳蕾,谢瑞芳,等.基于网络药理学的金复康口服液治疗非小细胞肺癌机制[J].中成药,2019,41(7):1547-1555.
[12] 曲 萌,解 英.中医药治疗肺癌的作用机制研究进展[J].国际中医中药杂志,2017,39(2):182-185.
[13] 于 奇,冯 海.小檗碱抗肿瘤机制研究[J].哈尔滨医科大学学报,2018,52(3):112-115.
[14] 张宏博,翟静波,单丽珠.中草药辅助治疗晚期非小细胞肺癌随机对照临床试验报告质量评估[J].国际生物医学工程杂志,2018,41(2):182-186.
[15] Li J,Liu F,Jiang SL.Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways[J].Oncology Letters,2018,15(5):7409.
[16] 崔 宏,高琴琴,王效谦,等.白花蛇舌草注射剂调节Bcl-2/CytC信号通路诱导线粒体凋亡抑制肝癌细胞增殖的研究[J].陕西中医,2019,40(4):418-420.
[17] 李 琴,付振明.非小细胞肺癌新辅助化疗的现状分析[J].国际肿瘤学杂志,2019,46(2):109-112.
[18] Ai XH,Mao F,Shen SP,et al.Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway[J].Bmc Cancer,2018,18(1):407.

相似文献/References:

[1]刘春燕,罗小燕,刘慧玲.沙参麦冬汤加减辅助吉非替尼对老年晚期非小细胞肺癌患者免疫功能及不良反应的影响*[J].陕西中医,2020,(2):183.
　LIU Chunyan,LUO Xiaoyan,LIU Huiling..Effects of modified Shashen Maidong decoction combined with gefitinib on immune function and adverse reactions in elderly patients with advanced non-small cell lung cancer[J].,2020,(1):183.
[2]梁应凤,郭姗姗,张 丹,等.健脾益肾方对非小细胞肺癌细胞体外增殖凋亡作用的实验研究*[J].陕西中医,2020,(5):574.[doi:DOI:10.3969/j.issn.10007369.2020.05.006]
　LIANG Yingfeng,GUO Shanshan,ZHANG Dan,et al.Effect of Jianpi Yishen prescription on proliferation and apoptosis of non-small cell lung cancer cells in vitro[J].,2020,(1):574.[doi:DOI:10.3969/j.issn.10007369.2020.05.006]
[3]贾 方,王秋月,崔文静,等.金复康口服液对Lewis肺癌荷瘤小鼠PD-1、PD-L1表达及相关免疫因子的影响*[J].陕西中医,2020,(10):1347.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.001]
　JIA Fang,WANG Qiuyue,CUI Wenjing,et al.Effect of Jinfukang oral liquid on the expression of PD-1,PD-L1 and related immune factors in tumor microenvironment of mice bearing Lewis lung carcinoma[J].,2020,(1):1347.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.001]

备注/Memo

备注/Memo:
基金项目:辽宁省科学事业公益研究基金资助项目(2016003006)
更新日期/Last Update: 2021-01-11